Detroit R&D

Detroit R&D: Building Trust Through Leading-Edge Technology

Founded in 1997 by Dr. Hyesook Kim, Detroit R&D is a company committed to developing high-quality products using cutting-edge technology. Based in Detroit, the company has established itself as a global source for innovative diagnostic and drug-screening products.

Leading-Edge Technology in Multiple Fields

Detroit R&D started with a project to develop inexpensive hypertension kits, and now leads the way in various areas, such as hypertension, stroke, cardiovascular diseases, diabetes, cancer biomarkers, environmental estrogens, COX-2 biomarkers, and more. Its product portfolio includes ELISA, ANTIBODIES, ASSAY KITS, and BIOTARGET™ HYPERTENSION ELISA.

Proven Track Record of Success

With its extensive product range, Detroit R&D has achieved success by selling to researchers worldwide and receiving 18 National Institutes of Health SBIR Phases I and II awards worth over 10 million dollars. The company has also been granted eight patents, with six pending.

A Commitment to Employee Well-Being and Society

The managing personnel at Detroit R&D is dedicated to developing and training employees who contribute to human well-being. Additionally, Detroit R&D is committed to partnering in the improvement of Detroit and providing in-depth customer services.

Collaboration and Licensing Opportunities

Detroit R&D has the talent and insight to continue its substantial growth. The company welcomes collaboration and/or licensing inquiries.

Search for products by Detroit R&D

Detroit R&D products by Research Area

• 
  Assisted reproductive technologies
• 
  Cardiovascular Research
• 
  Metabolism
• 
  Neuroscience
• 
  Oncology